Sign in

NCT00956579Completed

Sensory and Connectivity Abnormalities in Autism Spectrum Disorders

MEG/EEG/MRI and Psychophysics Study of Developmental Disorders

Source: ClinicalTrials.gov · Last updated 24 Apr 2026

Brief summary (registry, in English)

Study the neural substrates of autism spectrum disorders using neuroimaging methods such as MEG/EEG/MRI.

Status (registry)
Completed
Study type
Observational
Enrollment
85 (actual)
First submitted
23 Oct 2007
Start date
Jun 2013
Primary completion date
Jun 2025
Lead sponsor
Massachusetts General Hospital
Diseases
Autism
NCT number
NCT00956579

What you commit to

  • Study type: Observational
  • Participants enrolled: 85
  • From Jun 2013 to the primary completion date, Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The following exclusion criteria apply to both control and autism groups:
    • Any volunteer for whom informed consent cannot be obtained
    • Volunteers with metal braces, extensive dental work involving metals, implanted electromagnetically activated medical equipment (cardiac pacemakers, neurostimulators, functioning infusion pumps), all of which would interfere with the MEG signal, will be excluded from the MEG portion of the study
    • Volunteers with any medically diagnosed sensory loss
    • Volunteers with a known genetic disorder (e.g. Tourette's syndrome, etc), or other medical condition affecting the brain, such as progressive encephalopathy as well as those who are on high doses of multiple anti-seizure medications and have frequent, uncontrolled seizures
    • Asphyxia at birth or any other time, premature birth (Fewer than 34 weeks gestation)
  • For the control group only:
    • Volunteers diagnosed with a mental condition such as depression, anxiety, aggression, hyperactivity, attention deficit disorder (with or without hyperactivity).
    • Volunteers who score below the autism spectrum cut-off (in the normal range) on the ADOS and SCQ
    • Volunteers on any sort of neuro-psychopharmacological treatment (including antidepressants, stimulants, antipsychotics, anticonvulsants, benzodiazepines).
  • For the autism group only:
    • Children or adults not meeting criteria for autism spectrum disorder
    • Volunteers with co-morbid disorders such as tuberous sclerosis or fragile X.

Who the study is looking for

  • All of the following criteria must be met by all participants:
    • The participant or the participant's legal guardian is able to understand and is willing to comply with the requirements of the study
    • The participant meets the age requirements (14-32 years old)
    • The participant or legal guardian has signed an Informed Consent Form specific to this study, and is able to understand the consent form.
    • The participant must have English as their first language.
    • The participant must have a non-verbal IQ \> 70
  • For the ASD/language disorder group only:
    • Autism Spectrum Disorder: Participants must meet criteria for Autism Spectrum Disorder on the ADOS.

Age in the registry: 14 years to 32 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Martinos Center or Biomedical Imaging
Coordinator of this site? Confirm its status
CharlestownUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.